Vulva cancer is a cancer that starts in the outer female genital area, and it most often affects older adults. The early symptoms of vulva cancer can include itching, pain, burning, bleeding, or a sore, lump, or patch of skin that does not heal. It may help to know that doctors have studied this condition for decades, and vulva cancer can sometimes develop slowly over months or years, though some cases grow faster. Treatment for vulva cancer often involves surgery, and some people also need radiation therapy or chemotherapy. The outlook for vulva cancer depends on the stage at diagnosis, but survival is often better when it is found and treated early.
How many people live with Vulva cancer?
A recent global cancer database estimates that about 140,000 people worldwide were living with vulva cancer within 5 years of being diagnosed (Global Cancer Observatory, 2022). In the United States, estimates based on national cancer registry data suggest roughly 20,000 to 25,000 people were living with vulva cancer within 5 years of diagnosis (SEER Program, 2021).
Overview
Vulva cancerSymptoms
Vulva cancer often causes itching that does not go away, burning, pain, or tenderness. Many with vulva cancer notice a lump, sore, skin color change, or bleeding. Early symptoms of vulva cancer can also include pain during sex or urination.
Outlook and prognosis
The outlook for vulva cancer is often good when it is found early and treated before it spreads. Prognosis depends mainly on the stage, lymph node involvement, and overall health, and many people with vulva cancer do well with treatment.
Causes and risk factors
Vulva cancer risk rises with older age, smoking, long-term human papillomavirus infection, and weakened immunity. Chronic vulvar skin conditions can also raise risk. Some cases are linked to inherited cancer syndromes, but many have no clear single cause.
Genetic influences
Genetics usually play a limited role in vulva cancer. Most cases are linked more to age, long-term skin changes, smoking, or HPV infection than to inherited gene changes, though rare families may have a higher risk.
Diagnosis
Vulva cancer is diagnosed with a pelvic exam and a close look at any sore, lump, or skin change. Doctors usually confirm it with a small tissue sample called a biopsy, and may use imaging to check spread.
Treatment and drugs
Treatment for vulva cancer often includes surgery to remove the cancer, sometimes with nearby lymph nodes. Some people also need radiation, chemotherapy, or both, especially if vulva cancer is larger, has spread, or comes back.
Symptoms
Vulva cancer often shows up as a change on the skin of the vulva that does not go away, such as itching, a sore, or a new lump. Early signs can be mild, so many people first think it is irritation, a skin problem, or an infection. Symptoms vary from person to person and can change over time. Because several common conditions can look similar, a persistent change should be checked.
Itching, burning, or irritation around the vulva that lasts for weeks is one of the most common symptoms of vulva cancer. It may seem like dryness, shaving irritation, or a yeast infection at first, but it does not settle as expected.
The skin may become lighter, darker, redder, thicker, or rougher than the area around it. Some people notice a wart-like bump or a patch that feels different when washing or getting dressed.
A new lump, raised area, or thickened patch can be one of the early symptoms of vulva cancer. It may be small and painless at first, or it may slowly become tender with walking or sitting.
A sore, crack, or ulcer that does not heal is an important warning sign. It can sting, ooze, crust over, or seem to improve for a short time and then come back.
How people usually first notice Vulva cancer?
Vulvar cancer is often first noticed as a spot on the vulva that does not go away, especially an area of itching, burning, pain, skin thickening, or a lump that feels different from the surrounding tissue. Many people with vulvar cancer first see a patch that looks red, white, or darker than usual, or they notice a sore, wart-like bump, bleeding, or discharge that is not linked to a period. These changes are often caused by less serious conditions, too, but if a symptom lasts for weeks or keeps coming back, it is worth getting checked so the cause can be found early.
Types of Vulva cancer
Vulva cancer can feel different from one person to another, and the day-to-day changes are often what people notice first, such as ongoing itching, a sore that does not heal, or a new lump. Symptoms don’t always look the same for everyone. The main types of vulva cancer are based on which cells the cancer starts in, and that can affect where it appears, how fast it grows, and the symptoms it causes. Early symptoms of vulva cancer may be subtle, especially in the more common slow-growing forms.
Squamous cell
This is the most common type of vulva cancer and usually starts in the thin skin covering the vulva. It often causes long-lasting itching, burning, pain, skin thickening, or a sore, patch, or lump that does not go away. Some growths are slow to change, while others may bleed or become tender.
Adenocarcinoma
This type starts in gland tissue, including the Bartholin gland near the vaginal opening. It may feel more like a deeper lump or swelling than a surface skin change. Some people notice pain, pressure, or a mass that seems to keep growing.
Melanoma
This type begins in pigment-making cells and may look like a dark, uneven, or changing spot on the vulva. It can also itch, bleed, or become raised over time. Compared with other types of vulva cancer, it may be more noticeable because of a change in color.
Basal cell
This is an uncommon type that usually grows slowly on the vulvar skin. It may appear as a small bump, scaly area, or sore that keeps returning instead of healing fully. Pain is not always prominent early on, which can make it easy to overlook.
Sarcoma
This rare type starts in deeper supportive tissues such as muscle, fat, or blood vessel tissue. It often shows up as a growing lump or swelling rather than a surface patch or sore. Some may find it becomes noticeable because of pressure, discomfort, or rapid growth.
Verrucous carcinoma
This is a rare, slow-growing form of squamous cell cancer that can look wart-like or bulky. It often causes irritation, discharge, or a large outward-growing mass rather than a small ulcer. Even though it may grow slowly, it still needs prompt medical assessment.
Can I slow down the onset of symptoms?
Partly: no lifestyle change can guarantee that vulva cancer will not happen, but some steps can lower risk and may delay problems for some people. The best-supported steps are not smoking, getting the HPV vaccine if it is recommended for you, and getting care for long-lasting vulvar itching, skin thickening, sores, or other skin changes, since early treatment of these problems may lower risk or catch changes before cancer starts. There is no routine screening test for vulva cancer for most adults, so regular checkups and quick attention to new symptoms are the main medical steps; they can help find problems early, but they do not promise prevention.
What genetics can tell you about symptoms
Genetics can give doctors some clues about how vulvar cancer develops and, in some cases, how quickly it may grow, but they usually cannot predict exactly which symptoms someone will notice day to day. Different genetic changes are linked to different types of vulvar cancer, including cancers related to HPV infection and others more often tied to changes in genes that help control cell growth, and these differences can affect how aggressive the cancer is and sometimes the age when it starts. Even so, symptoms such as itching, pain, a lump, skin changes, or bleeding are usually shaped more by where the cancer is, how large it is, and how far it has spread than by genetics alone.
Causes and risk factors
Many people want to understand the main risk factors for vulva cancer. Risk rises with older age, HPV infection, and certain long-term skin conditions that affect the vulva. Smoking and a weakened immune system can also make vulva cancer more likely. Family history and rare inherited gene changes may play a part, but most vulva cancer is not strongly inherited. It’s rarely just one factor—it’s the mix that matters.
What are the most common causes or risk factors?
The most common risk factors for vulvar cancer are older age, infection with HPV, a very common virus spread through sexual contact, and smoking. Risk is also higher in people with a weakened immune system, long-lasting skin problems of the vulva such as an itchy scarring condition called lichen sclerosus, or past abnormal cell changes in the vulva or cervix. Inherited gene changes are not a common cause, so family history usually matters less than these non-genetic risk factors.
Environmental and biological risk factors
Vulva cancer is more likely in some situations than others, although many people with risk factors never develop it. The main risk factors for vulva cancer are older age, certain long-lasting infections or skin conditions, and anything that weakens the immune system. Doctors often group risks into internal (biological) and external (environmental). Knowing these patterns can help guide checkups and prompt attention to new symptoms.
Vulva cancer becomes more common with age, especially after menopause. Risk rises over time because abnormal cell changes have longer to develop.
A long-lasting infection with high-risk human papillomavirus can raise the chance of vulva cancer. This pathway is often more important in younger adults than in older adults.
This long-term vulvar skin condition can cause itching, soreness, and fragile skin. Over time, ongoing inflammation and skin damage can increase the risk of vulva cancer in a small number of people.
Certain abnormal cell changes on the vulva can turn into cancer if they are not found and treated. This is why persistent patches, sores, or color changes on the vulva should be checked.
Genetic risk factors
Most vulva cancer cases are not strongly inherited, and a single passed-down gene is uncommon. Some risk factors are inherited through our genes. Rare DNA-repair conditions can raise risk, and cancer cells often pick up their own gene changes as they grow. Because the exact pattern varies by subtype, the genetic risk factors for vulva cancer are not the same for everyone.
Usually not inherited: Most people with vulva cancer do not have a clear inherited mutation causing it. A diagnosis in one relative does not automatically mean other family members will develop the disease.
Family history: A strong family history of vulva or certain related cancers can sometimes suggest an inherited tendency. On its own, though, family history is only a clue and not proof of a genetic cause.
Fanconi anemia: People born with Fanconi anemia have a clearly higher risk of squamous cell cancers, including vulva cancer. This condition weakens the body's ability to repair DNA, so abnormal cells can build up more easily.
TP53 changes: Some squamous vulva cancers have changes in a gene called TP53. This gene normally helps damaged cells stop dividing or die off, and these changes are usually found only in the tumor.
PIK3CA or HRAS: Some vulva cancers carry changes in genes such as PIK3CA or HRAS, which help control cell growth signals. These changes are usually acquired in the cancer cells themselves rather than passed down through families.
Subtype differences: The gene changes behind vulva cancer can differ between squamous cancer, melanoma of the vulva, and rarer gland-based tumors. This is one reason doctors may choose different genetic tests depending on the exact subtype.
Lifestyle risk factors
Several everyday habits can affect the chance of developing vulva cancer, mainly by increasing long-term irritation, lowering immune defenses, or making it harder for the body to clear HPV infection. Smoking is the clearest lifestyle-related risk factor, while sexual behaviors that raise HPV exposure also matter. Other habits, such as poor genital skin care and delayed medical attention for persistent vulvar symptoms, may contribute to progression or later diagnosis. When people ask about lifestyle risk factors for vulva cancer, these are the most relevant factors to address.
Tobacco use is one of the strongest lifestyle factors linked to vulva cancer. It can weaken local immune responses and make it harder for the body to clear high-risk HPV infection.
Having multiple sexual partners or unprotected sex can increase exposure to HPV, which is involved in many vulvar cancers. Safer sex practices may lower the chance of persistent HPV infection over time.
Skipping regular gynecologic care can allow HPV-related precancerous changes in the lower genital tract to go unnoticed. Staying engaged with screening and follow-up can help detect related abnormalities earlier.
Ongoing scratching, friction, or neglect of chronic vulvar itching and skin changes may worsen tissue damage and delay recognition of precancerous disease. Early evaluation of symptoms such as itching, pain, burning, or skin color change is important.
Risk prevention
Vulva cancer cannot always be prevented, but there are clear steps that can lower the risk, especially by reducing long-term irritation, avoiding tobacco, and treating infections linked to cell changes. Many living with vulva cancer had no obvious warning early on, which is why prevention also includes noticing lasting itching, pain, skin changes, or a sore that does not heal. Prevention is about lowering risk, not eliminating it completely. For many, learning how to reduce the risk of vulvar cancer also means keeping up with routine gynecologic care and acting early when symptoms appear.
Vaccination against human papillomavirus, or HPV, can lower the risk of the cell changes that may lead to vulva cancer. Safer sex, including condom use, may also reduce HPV spread, although it does not remove the risk completely.
Smoking makes it harder for the body to clear HPV and is linked to a higher risk of several genital cancers, including vulva cancer. Quitting can help at any age, and support programs, medicines, or nicotine replacement often improve success.
Ongoing vulvar skin problems, especially lichen sclerosus, can raise the risk of vulva cancer if they are not treated and monitored. Using prescribed treatment and follow-up visits can calm inflammation and help catch concerning changes early.
A patch of thicker skin, itching that keeps coming back, burning, bleeding, or a lump should not be ignored if it lasts more than a few weeks. Early symptoms of vulvar cancer can look like common skin irritation, so getting checked sooner can lead to earlier treatment.
Can you prevent Vulva cancer?
You cannot fully prevent vulva cancer, but some cases may be less likely with the right steps. Getting the HPV vaccine, not smoking, and having ongoing vulva itching, burning, sores, or skin changes checked early can lower risk, because some vulva cancers start after long-term irritation or from a common virus called HPV. Even with these steps, prevention is not guaranteed, and some people develop vulva cancer without any clear reason.
Transmission
Vulva cancer is not infectious, so it cannot be passed from one person to another through sex, kissing, touching, sharing towels, or using the same toilet. If you are wondering whether Vulva cancer is contagious, the answer is no.
Some cases of Vulva cancer are linked to human papillomavirus, or HPV, which can spread through sexual contact, but the infection itself is not the same as the cancer. In other cases, Vulva cancer develops without HPV and is related to changes in the skin cells over time, so there is no direct transfer of the cancer itself between people.
When to test your genes
Genetic testing is not routinely used to detect vulvar cancer early. Discuss it if your family has several cases of breast, ovarian, colon, or uterine cancer, or cancers at young ages. In advanced or recurrent vulvar cancer, tumor testing may sometimes guide treatment.
Diagnosis
Vulva cancer is usually diagnosed after a new symptom or skin change leads to an exam, such as itching that does not go away, a sore that will not heal, bleeding, or a lump. Doctors usually begin with a close look at the vulva and nearby skin, then use a small tissue sample to confirm whether cancer cells are present. It’s natural to worry when symptoms don’t have a clear explanation, but the diagnosis of vulva cancer often becomes clearer step by step.
Your doctor will ask about symptoms, how long they have been present, and whether there have been changes such as pain, itching, bleeding, or a visible sore. A detailed family and health history can help point to possible risk factors and guide the next tests.
During the exam, the doctor looks closely at the vulva and checks the vagina, cervix, and surrounding skin for any suspicious areas. They may also feel the groin to check for enlarged lymph nodes.
A biopsy is the main test used to confirm vulva cancer. A small sample of tissue is removed from the abnormal area and examined under a microscope to see whether cancer or precancer is present.
A pathologist studies the biopsy sample to identify the type of cancer and how deeply it has grown into nearby tissue. This information helps confirm the diagnosis of vulva cancer and supports treatment planning.
How is Vulva cancer diagnosed?
Vulva cancer is usually diagnosed after a clinician asks about symptoms and does an exam of the vulva, often looking closely at any sore, lump, color change, or patch of skin that is not healing. The only way to confirm it is with a biopsy, which means taking a small tissue sample from the area and checking it under a microscope. If cancer is found, scans such as ultrasound, CT, MRI, or PET may be used to see whether it has spread, and genetic testing is not usually the main way vulva cancer is diagnosed.
Stages of Vulva cancer
For many living with vulva cancer, the stage describes how far the cancer has spread at the time of diagnosis, which helps guide treatment and gives a clearer sense of what comes next. Early and accurate diagnosis helps you plan ahead with confidence. In many cases, early symptoms of vulva cancer can be vague, such as itching, soreness, or a skin change that does not go away, so staging usually relies on an exam, a biopsy, and imaging tests.
Stage 1
The cancer is only in the vulva or nearby perineal area, which is the skin between the vaginal opening and anus. It has not spread to nearby lymph nodes or distant parts of the body.
Stage 2
The cancer has grown into nearby structures such as the lower part of the urethra, lower vagina, or anus. It still has not spread to nearby lymph nodes or distant organs.
Stage 3
The cancer may be in the vulva and nearby tissues, and it has spread to lymph nodes in the groin. Different tests may be suggested to help show how many nodes are involved and how large those areas are.
Stage 4
The cancer has spread more widely, such as into the upper urethra, upper vagina, bladder, rectum, pelvic bone, or to distant parts of the body. This is the most advanced stage, but treatment can still help control the disease and ease symptoms.
Outlook and prognosis
The outlook for vulva cancer depends mainly on the stage at diagnosis, lymph node involvement, and the person’s overall health. When found early and confined to the vulva, treatment is often successful and long-term survival is generally favorable, whereas cancers that have spread to nearby lymph nodes or distant organs carry a worse prognosis. In general, localized vulva cancer has a much higher 5-year relative survival than regional or metastatic disease, with survival dropping substantially once there is distant spread. Recurrence can occur, especially in the first few years after treatment, so close follow-up is important. Mortality is lower for small, early-stage tumors and higher for advanced, recurrent, or treatment-resistant disease. Age, tumor size, margin status after surgery, and whether the cancer is linked to HPV or chronic vulvar skin disease can also influence outcomes.
Long-term effects
For many people, the long-term picture with vulva cancer depends a lot on how early it was found and whether it had spread to nearby lymph nodes. When vulva cancer is treated at an early stage, many people do well, but some can still have lasting changes from surgery, radiation, or both. It’s important to remember that long-term doesn’t always mean progressive. Some effects improve over time, while others may need ongoing follow-up.
One of the main long-term concerns is that vulva cancer can come back in the vulva area, nearby lymph nodes, or more distant parts of the body. The chance of recurrence of vulva cancer is usually higher when the original cancer was larger, deeper, or had already spread.
Surgery can leave scarring, tightness, or changes in the shape of the vulva that may remain long term. For many, this can make sitting, walking, cycling, or wearing tighter clothing less comfortable.
Some people have ongoing pain, burning, tenderness, or numb areas after treatment, especially if nerves were affected during surgery or radiation. These changes can be mild for some and more persistent for others.
Vulva cancer and its treatment can affect sexual comfort, desire, and intimacy. Many living with vulva cancer notice dryness, pain with sex, or worry about how the area looks and feels afterward.
How is it to live with Vulva cancer?
Living with vulva cancer can make everyday life feel more complicated in very personal ways, because symptoms such as pain, itching, burning, bleeding, or discomfort with sitting, walking, urinating, or sex can affect routines that most people usually do without thinking. Treatment can add its own challenges, including fatigue, wound care after surgery, changes in body image, and emotional strain, so many living with vulva cancer need extra rest, practical help, and honest support from the people around them. Partners, family, and close friends may also feel worried or unsure how to help, but clear communication and support from the care team often make daily life more manageable and less isolating.
Treatment and drugs
Treatment for vulva cancer depends on the size and stage of the cancer, where it is on the vulva, and your overall health, but surgery is often the main treatment. Some people need only a small operation to remove the cancer and a margin of healthy tissue, while others may also need lymph nodes in the groin checked or removed to see if the cancer has spread. Treatment plans often combine several approaches, and vulva cancer may also be treated with radiation, chemotherapy, or both, especially if the cancer is larger, has spread, or comes back after treatment. For many living with vulva cancer, medicines are most often used as part of chemotherapy or to help with pain, nausea, skin irritation, and other side effects during treatment.
Can you cure Vulva cancer?
Vulva cancer can sometimes be cured, especially when it is found early and treated before it has spread. Treatment often includes surgery, and some people also need radiation or medicine to kill cancer cells; these treatments can remove the cancer, lower the chance of it coming back, and help with symptoms. If the cancer is more advanced, a full cure may not be possible, but treatment can still help people live longer and feel better.
Non-drug treatment
Treatment for vulva cancer often includes procedures and therapies that remove or destroy the cancer while also protecting comfort, mobility, and sexual health as much as possible. For many, treatment begins not at the pharmacy, but with surgery, radiation, or both, depending on the size and location of the cancer and whether lymph nodes are involved. Supportive care also matters, especially during recovery, because everyday tasks like sitting, walking, urinating, or having sex may feel different for a time. If you are wondering about the best non-drug treatment for vulva cancer, the answer depends on the stage of the cancer and your overall health.
Surgery is the main non-drug treatment for many people with vulva cancer. It may involve removing only the tumor with a rim of healthy tissue, or a larger operation if the cancer has spread farther.
Doctors may also remove or test nearby groin lymph nodes to check whether the cancer has spread. This helps guide treatment decisions and can improve the accuracy of staging.
Radiation uses high-energy beams to destroy cancer cells and may be used instead of surgery, before surgery, or after surgery. Some people with vulva cancer receive it to lower the chance of the cancer coming back in the same area.
Pelvic floor physical therapy can help with pain, tightness, bladder or bowel symptoms, and discomfort during sex after treatment. Supportive therapies can also improve movement and confidence during recovery.
Your genes may have an impact on how drugs work for you
Genes can sometimes affect how your body handles cancer medicines, which may change how well a treatment works or how strongly side effects show up; for example, some people break down medicine more slowly, so problems like severe nausea, low blood counts, or skin reactions can be more likely. In vulvar cancer, this is not yet a routine part of care for most treatments, but doctors may think about personal and family history, other health conditions, and sometimes tumor testing when choosing treatment. For many living with vulvar cancer, this means the best medicine is often found by matching treatment to the cancer and watching closely to see how their body responds.
Pharmacological treatments
Drug treatment for vulva cancer is most often used when the cancer is advanced, has spread, has come back, or is being treated along with radiation. Medication can feel like a big step, but the exact drugs depend on the cancer stage, a person’s overall health, and sometimes tumor test results. In many living with vulva cancer, these medicines are used to shrink tumors, make radiation work better, or help control symptoms when surgery is not enough.
Cisplatin is one of the most commonly used drugs for vulva cancer, especially when it is given with radiation. It helps damage cancer cells and can make radiation treatment more effective.
Carboplatin is a related platinum drug that may be used instead of cisplatin, especially if kidney function, hearing problems, or other side effects make cisplatin harder to tolerate. It is often part of treatment for advanced or recurrent vulva cancer.
5-fluorouracil, often called 5-FU, may be used with radiation or sometimes with other chemotherapy drugs for vulva cancer. It works by slowing the growth of fast-dividing cancer cells.
Paclitaxel is often used for vulva cancer that has spread or returned after earlier treatment, sometimes together with a platinum drug such as cisplatin or carboplatin. Hair loss, numbness or tingling in the hands and feet, and low blood counts can happen with this medicine.
Genetic influences
Most cases of vulva cancer are not caused by a single inherited gene passed through a family. It’s natural to ask whether family history plays a role. In vulva cancer, inherited genetics usually play a smaller part than gene changes that build up over time in vulvar cells, often alongside factors such as human papillomavirus (HPV) infection or chronic skin conditions of the vulva.
That said, a strong family history of vulva cancer or several cancers in close relatives may lead a doctor to look more closely at inherited cancer risk. This is uncommon, but genetic counseling and sometimes testing may be considered if vulva cancer develops at a younger age than expected or if there is a broader pattern of cancer in the family. For many living with vulva cancer, genetics is just one part of the picture, and having a family history does not mean you will develop the disease.
Is Vulva cancer genetic?
Genetics usually play a limited role in vulva cancer. Most cases are linked more to age, long-term skin changes, smoking, or HPV infection than to inherited gene changes, though rare families may have a higher risk.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are common and are a normal feature of human biology. Most do not directly affect health and simply contribute to the natural differences seen among people. For many genes, having a variant associated with a condition suggests a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-understood variant in a particular gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
Treatment for vulva cancer is usually guided first by where the cancer is, whether it has spread, and your overall health, but genes can matter too. In some people with advanced or recurrent vulva cancer, doctors may test the tumor for certain genetic or molecular changes that can help show whether immunotherapy or another targeted treatment is worth considering. Not every difference in response is genetic, but inherited differences in how your body handles medicine can sometimes affect which drugs are safest and what dose is most suitable. For example, if chemotherapy is being considered, genetic testing may occasionally help explain a higher risk of severe side effects with certain medicines. This means that genetic testing for vulva cancer treatment is usually not the main factor, but for some people it can help fine-tune care when standard options are limited or when side effects are a concern.
Interactions with other conditions
Living with vulva cancer can be more complicated when other health problems are also present, because symptoms such as pain, itching, skin changes, or fatigue can overlap and be harder to sort out. Vulva cancer is often linked with long-term skin conditions of the vulva, especially lichen sclerosus, which can raise the risk of cancer over time and may make early symptoms of vulva cancer easier to miss. It can also occur alongside infections caused by human papillomavirus, or HPV, and people with a history of cervical, vaginal, or anal precancer or cancer may need closer follow-up because these conditions can share the same underlying risk factors. Many people live with more than one health issue at a time. Diabetes, poor circulation, or immune system problems may also affect how well the area heals after surgery or other treatment, and smoking-related lung or heart disease can make treatment harder on the body. Depression, anxiety, and sexual pain disorders may become more noticeable during diagnosis and treatment, so it helps to talk openly with your care team about both physical and emotional health.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Vulva cancer?
Symptoms of vulva cancer, such as itching, burning, pain, bleeding, a sore that does not heal, or a new lump, can also happen with more common problems like skin irritation, eczema-like rashes, long-lasting skin conditions such as lichen sclerosus, yeast or other infections, genital herpes or warts, or a blocked gland near the vaginal opening called a Bartholin cyst. Sometimes early abnormal cell changes in the vulva or cancers nearby, such as vaginal or cervical cancer, can also cause similar symptoms. Because these problems can look alike, any vulvar change that lasts more than a few weeks should be checked by a doctor.
History
Vulva cancer has been recognized for a long time, but earlier doctors often grouped many different vulvar skin and tissue problems together. That meant some people living with vulva cancer were not clearly diagnosed until the disease was quite advanced, after months of itching, soreness, bleeding, or a lump that did not go away.
As medical science evolved, doctors began to separate vulva cancer from infections, cysts, and other noncancerous conditions that can affect the outer genitals. This mattered in everyday life. Someone might have been treated again and again for irritation or a skin problem, when the real issue was cancer developing slowly in the vulva.
During the 19th and early 20th centuries, surgery became the main treatment, but operations were often extensive and could be physically and emotionally difficult. Over time, better anesthesia, safer surgery, and more careful pathology testing helped doctors understand how far the cancer had spread and how much treatment was truly needed. This gradually led to more tailored care rather than a one-size-fits-all approach.
In the second half of the 20th century, researchers learned that vulva cancer is not just one single pathway of disease. Some cases are linked to long-standing skin changes of the vulva, while others are associated with human papillomavirus, or HPV. That shift helped explain why vulva cancer can affect different age groups and why the early symptoms of vulva cancer may look different from one person to another.
In recent decades, awareness has grown around the importance of checking persistent vulvar symptoms instead of assuming they are minor or temporary. Better imaging, more precise surgery, radiation, and drug treatments have improved care, and screening for related conditions has helped doctors detect some changes earlier. Today, the history of vulva cancer is also a story about listening more carefully to symptoms that were once overlooked, so people can get answers and treatment sooner.